Promino Nutritional Sciences Inc. Provides Corporate Update

Rhea-AI Summary

Promino Nutritional Sciences (OTC:MUSLF) announced key updates regarding its product reformulation and regulatory challenges. The company has completed reformulating its Rejuvenate Muscle Health™ and Promino™ products with a new amino acid blend, eliminating the need for patent sublicense expenses.

EightIP LLC, the former patent sublicensor, has terminated their agreement and filed a claim in Nevada for unpaid royalty fees. Additionally, the company is working with auditors to file outstanding financial reports to address a cease trade order imposed on May 8, 2025 by the Ontario Securities Commission.

Positive

• New product formulation eliminates future patent sublicense expenses
• Company reports product continues to deliver excellent results despite reformulation

Negative

• Legal claim filed by EightIP LLC for unpaid royalty fees
• Trading suspended due to cease trade order from Ontario Securities Commission
• Outstanding financial reports remain unfiled

Burlington, Ontario--(Newsfile Corp. - August 7, 2025) - Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC Pink: MUSLF) (FSE: 93X) (the "Company" or "Promino") wishes to advise that it has completed a reformulation of its Rejuvenate Muscle Health™ and Promino™ products, which now rely on a new amino acid blend. The reformulated product no longer relies on the patented formulation previously employed by the Company, eliminating the need to incur future patent sublicense expenses, while still delivering excellent results for our customers.

EightIP LLC, the patent sublicensor in respect of the Company's legacy product formulation, has terminated the sublicense agreement in respect of the patent which was relied upon by the Company's legacy product formulation (see the Company's news release of December 6, 2023 for more information), and filed a claim in the state of Nevada for damages in respect of unpaid royalty fees and related remedies. On review of the claim, there are a number of defences available to the Company, and the Company is working to achieve an amicable settlement. Updates will be provided in due course.

The Company also advises that it is working diligently with its auditors to file outstanding financial reports in an effort to become eligible to have the ongoing cease trade order imposed on May 8, 2025 by the Ontario Securities Commission revoked so that it may resume trading on the Canadian Securities Exchange. Updates will similarly be provided in due course.

About Promino

Promino is an innovative and research driven Canadian nutraceutical company specializing in the development of science-based products for the global consumer packaged goods market, with a portfolio focused specifically on muscle health. Promino's lead product, Rejuvenate Muscle Health™ now benefits from a new formulation that aims to assist in the building, rebuilding, restoration and rejuvenation of natural muscle mass. Promino also offers Promino™, an elite performance supplement for both professional and amateur athletes to accelerate muscle recovery, build strength and accelerate recovery from injury. Promino was founded in 2015 and is located in Burlington, Ontario.

For more information about Rejuvenate Muscle™ Activator and where to purchase, visit www.rejuvenatemuscle.com.

To learn more about Promino, visit www.drinkpromino.com.

Forward-Looking Statements

This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. All statements that address activities, events, or developments that the Company expects or anticipates will, or may, occur in the future, are forward-looking statements, including statements regarding the Company's cease trade order, the status of ongoing litigation, continuous disclosure filings and business prospects. In some cases, forward-looking statements are preceded by, followed by, or include words such as "may", "will," "would", "could", "should", "believes", "estimates", "projects", "potential", "expects", "plans", "anticipates", "continues", or the negative of those words or other similar or comparable words. In preparing the forward-looking statements in this news release, the Company has applied several material assumptions, including, but not limited to prompt completion of the FY 2024 audit, and that general business and economic conditions will not change in a materially adverse manner. These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors.

No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.

For further information about Promino:
Vito Sanzone, CEO, vsanzone@drinkpromino.com, 289-348-1970 ext. 222

Marc Charbin, Investor Relations, marc.charbin@loderockadvisors.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/261618

FAQ

What changes did Promino Nutritional Sciences (MUSLF) make to its products in 2025?

Promino reformulated its Rejuvenate Muscle Health™ and Promino™ products with a new amino acid blend, eliminating the need for patented formulation and associated sublicense expenses.

Why is Promino Nutritional Sciences stock not trading on the Canadian Securities Exchange?

Trading was suspended due to a cease trade order imposed by the Ontario Securities Commission on May 8, 2025, due to outstanding financial reports.

What legal challenges is Promino Nutritional Sciences (MUSLF) facing in 2025?

EightIP LLC has filed a claim in Nevada seeking damages for unpaid royalty fees following the termination of their patent sublicense agreement.

How is Promino Nutritional Sciences addressing its cease trade order?

The company is working with auditors to file outstanding financial reports to become eligible for the cease trade order to be revoked and resume trading on the Canadian Securities Exchange.